Both EU and UK medicines regulators have recently mandated the introduction of patient cards into packaging of finasteride which is used for management of both alopecia and benign prostatic hypertrophy.

An interesting perspective published in JAMA Network reminds us that the benefits of certain medications for certain patients may change over time.

There are a number of dosing protocols for the administration of IV N-acetylcysteine (NAC) following a toxic paracetamol ingestion.